微載體市場規模,佔有率,趨勢分析:各產品,各用途,各終端用戶,各地區展望,競爭策略,至2030年的各市場區隔預測
市場調查報告書
商品編碼
1089965

微載體市場規模,佔有率,趨勢分析:各產品,各用途,各終端用戶,各地區展望,競爭策略,至2030年的各市場區隔預測

Microcarrier Market Size, Share & Trends Analysis By Product, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 237 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球微載體的市場規模,預計今後以10.2%的年複合成長率擴大,至2030年達到40億7,000萬美元。由於氣候變動和人口增加,病毒發生的風險高漲。因此,成為微載體市場成長的機會

本報告提供全球微載體市場相關調查,市場概要,以及各產品,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長要素,阻礙因素,機會,課題的分析
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19微載體市場的影響

第5章 市場變數及預測

  • SWOT分析
  • PESTEL分析
  • 波特的五力分析
  • 熱圖分析

第6章 全球微載體市場,各產品,2019年~2030年(100萬美元)

  • 消耗品
    • 培養基
    • 試劑
    • 微載體
  • 設備
    • 生物反應器
    • 培養容器
    • 過濾及分離設備
    • 電池單元計數器
    • 其他

第7章 全球微載體市場,各用途,2019年~2030年(100萬美元)

  • 生物醫藥品生產
    • 疫苗生產
    • 治療性蛋白質生產
  • 細胞、基因治療
  • 組織工程及再生醫療
  • 其他

第8章 全球微載體市場,各終端用戶,2019年~2030年(100萬美元)

  • 製藥公司、生物科技企業
  • CRO,CMO
  • 學術研究機關
  • 電池單元銀行

第9章 全球微載體市場,各地區,2019年~2030年(100萬美元)

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 企業簡介

  • BD
  • CESCO Bioengineering
  • ChemoMetec
  • Corning
  • Danaher Corporation
  • Eppendorf AG
  • Fischer Scientific
  • HiMedia Laboratories
  • Merck
  • Sartorius AG
簡介目錄
Product Code: BIOT2231

Global microcarrier market is projected to be worth USD 4.07 billion by 2030.

According to SPER Market Research, the microcarrier market is estimated to reach USD 4.07 billion by 2030 with a CAGR of 10.2%. There is higher risk of virus outbreak due to climate change and increasing population. This creates opportunities for microcarrier market to grow.

Impact of COVID-19 on the Microcarrier Market

The outburst of COVID-19 infections at global level forced the governments to declare nation-wide lockdowns and norms for social distancing. The small and large players in pharmaceuticals focused on developing vaccines and other therapies against SARS-CoV-2 Research and development quickly escalated and were largely unaffected by the lockdowns and restrictions due to the support and funding. Demand for cell culture products also increased including microcarrier products. Cell culture is an important part of vaccine development which has increased the demand for microcarrier products.

Scope of the report:

  • Market size available for years: 2019-2030
  • Base year considered: 2021
  • Forecast period: 2022-2030
  • Segments covered: By Product, By Application, By End User
  • Geographies covered: North America, Europe, APAC, Latin America and the Middle East & Africa
  • Companies Covered: BD, CESCO Bioengineering, ChemoMetec, Corning, Danaher Corporation, Eppendorf AG, Fischer Scientific, HiMedia Laboratories, Merck, Sartorius AG

Driver: Increasing demand for cell-based vaccines

Rapidly increasing population, close proximity between animals and humans have created favorable conditions for virus outbreaks. This increases the demand for cell culture to develop cell-based vaccines. There is a higher risk of a pandemic in future creating urgent need for cell-based vaccines due to higher efficiency, large production capacity and shorter lead time. Clinical studies have also suggested cell-based vaccines as safe and effective for use in humans.

Restraints: High research and development cost

R&D in cell biology is an expensive process involving reagents and equipment of higher quality and precision in results. The high-quality standards issued by regulatory authorities increases the cost of the research. Thus, small players and academic institutes cannot afford to carry out this research which restraints the growth of this market in the forecast period.

Opportunity: Rising demand for monoclonal antibody

Monoclonal antibodies are increasing in demand for targeted delivery for cancer treatments and immune diseases. The monoclonal antibodies are administered at higher doses thus, production is also required equally high. This creates growth opportunities for microcarriers.

Microcarrier Market by Product:

Based on product, market has been segmented into Consumables (Media [Sera/Serum-based Media, Serum-free Media, Other Media], Reagents, Microcarriers [Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers]), Equipment (Bioreactors [Single-use Bioreactors, Stainless-steel Bioreactors], Culture Vessels, Filtration and Separation Equipment, Cell Counters, Other Equipment)

Microcarrier Market by Application:

Based on application, the market is segmented into Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications

Microcarrier Market by End User:

Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes, Cell Banks

Pharmaceutical & Biotechnological companies have the largest share of this market by end user due to changing regulatory scenarios of cell-based vaccines and rising awareness for cell-based vaccines for its benefits.

Microcarrier Market by Region:

North America owns the largest share of this market owing to increasing R&D activities, technological advancements, increasing investments and funding in cell-based research and presence of leading players of this market.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary data
    • 2.1.2. Primary data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impact of the Microcarrier Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL analysis
    • 5.2.1. Political landscape
    • 5.2.2. Economic landscape
    • 5.2.3. Social landscape
    • 5.2.4. Technological landscape
    • 5.2.5. Environmental landscape
    • 5.2.6. Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of Buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat map analysis

6. Global Microcarrier Market, By Product, 2019-2030 (USD Million)

  • 6.1. Consumables
    • 6.1.1. Media
      • 6.1.1.1. Sera/Serum-based Media
      • 6.1.1.2. Serum-free Media
      • 6.1.1.3. Other Media
    • 6.1.2. Reagents
    • 6.1.3. Microcarriers
      • 6.1.3.1. Collagen-coated Microcarriers
      • 6.1.3.2. Cationic Microcarriers
      • 6.1.3.3. Protein-coated Microcarriers
      • 6.1.3.4. Untreated Microcarriers
      • 6.1.3.5. Other Microcarriers
  • 6.2. Equipment
    • 6.2.1. Bioreactors
      • 6.2.1.1. Single-use Bioreactors
      • 6.2.1.2. Stainless-steel Bioreactors
    • 6.2.2. Culture Vessels
    • 6.2.3. Filtration and Separation Equipment
    • 6.2.4. Cell Counters
    • 6.2.5. Other Equipment

7. Global Microcarrier Market, By Application, 2019-2030 (USD Million)

  • 7.1. Biopharmaceutical Production
    • 7.1.1. Vaccine Production
    • 7.1.2. Therapeutic Protein Production
  • 7.2. Cell and Gene Therapy
  • 7.3. Tissue Engineering and Regenerative Medicine
  • 7.4. Other Applications

8. Global Microcarrier Market, By End User, 2019-2030 (USD Million)

  • 8.1. Pharmaceutical & Biotechnology Companies
  • 8.2. Contract Research Organizations & Contract Manufacturing Organizations
  • 8.3. Academic & Research Institutes
  • 8.4. Cell Banks

9. Global Microcarrier Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. BD
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. CESCO Bioengineering
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. ChemoMetec
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Corning
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Eppendorf AG
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Fischer Scientific
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. HiMedia Laboratories
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. Merck
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Sartorius AG
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments

9. Global Microcarrier Market, By Region, 2019-2030 (USD Million)

  • 9.1. North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4. South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5. Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10. Company Profiles

  • 10.1. BD
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2. CESCO Bioengineering
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3. ChemoMetec
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4. Corning
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5. Danaher Corporation
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6. Eppendorf AG
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7. Fischer Scientific
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8. HiMedia Laboratories
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9. Merck
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. Sartorius AG
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments